Doxylamine Succinate
2 Inquiries
562-10-7
99%
Guangzhou or Shenzhen
25kg/drum
2021-12-31
fluvoxamine ketone,3-Amino-4-pyrazolecarbonitrile,(2R,3R)-3-(3-Methoxyphenyl)-N,N-2-trimethylpentanamine,(alphaS,betaS)-beta-Amino-alpha-[[1-[[4-(2-pyrid,4-(2-Pyridinyl)benzaldehyde,Raltegravir
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Donormil
Other Name:Butanedioic acid,compd. with N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1);Succinic acid,compd. with 2-[α-[2-(dimethylamino)ethoxy]-α-methylbenzyl]pyridine (1:1);Pyridine,2-[α-[2-(dimethylamino)ethoxy]-α-methylbenzyl]-,succinate (1:1);Ethanamine,N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]-,butanedioate (1:1);Decapryn succinate (1:1);2-[α-(2-Dimethylaminoethoxy)-α-methylbenzyl]pyridine succinate (1:1);Decapryn;Unisom;Hoggar N;Decapryn succinate;Alsodorm;Gittalun;Sedaplus;2-[α-(2-Dimethylaminoethoxy)-α-methylbenzyl]pyridine succinate;Decamium;Doxised;Meraprina;Mereprine;NSC 74772;Donormil;Donormyl;Dormidina;121367-03-1;7047-26-9
CAS No.:562-10-7
Molecular Formula:C17H22N2O.C4H6O4
InChIKeys:InChIKey=KBAUFVUYFNWQFM-UHFFFAOYSA-N
Molecular Weight:388.46
Exact Mass:388.2
EC Number:209-228-7
NSC Number:756752|74772
DSSTox ID:DTXSID7020552
HScode:2933399090
Categories:
Characteristics-
PSA:
100
XLogP3:2.85910
Appearance:Doxylamine succinate appears as white or creamy white powder. pH (1% aqueous solution) between 4.9 and 5.1. (NTP, 1992)
Density:1.043g/cm3
Melting Point:100-104 °C
Boiling Point:364.9°C at 760 mmHg
Flash Point:9℃
Water Solubility:>58.3 [ug/mL]
Storage Conditions:Refrigerator
Toxicity:LD50 in mice, rabbits (mg/kg): 470, 250 orally; 62, 49 i.v.; in mice, male rats, female rats (mg/kg): 460, 440, 445 s.c. (Brown, Werner)
Collision Cross Section:162.6 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Air and Water Reactions:Water soluble.
Reactive Group:Acids, Carboxylic
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Acute toxicity - Category 4, Dermal
Acute toxicity - Category 4, Inhalation
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H312 Harmful in contact with skin
H332 Harmful if inhaled
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P317 Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
fluvoxamine ketone,3-Amino-4-pyrazolecarbonitrile,(2R,3R)-3-(3-Methoxyphenyl)-N,N-2-trimethylpentanamine,(alphaS,betaS)-beta-Amino-alpha-[[1-[[4-(2-pyrid,4-(2-Pyridinyl)benzaldehyde,Raltegravir
-
Payment Terms:
D/P,L/C
-
Average lead Time:
60
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
Zhuhai Hairuide Biological Technology Co., Ltd., established in February 2009, is a modern enterprise mainly engaged in R&D, production and sales of chemical raw materials, pharmaceutical intermediates, health foods, biological reagents, and cosmetics. The company's production base Located in Sanzao Technology Industrial Park, Jinwan District, Zhuhai City. The company's main products are pharmaceutical and chemical raw materials such as the side chain, main ring, mother core, intermediates and crude products of carbapenem antibiotics such as imipenem and biapenem. At the same time, the company also produces doxylamine succinate , Carbisamin maleate, triprolidine hydrochloride and other pharmaceutical and chemical products. Since its inception, the company has always adhered to the "development and production of cutting-edge pharmaceutical and chemical intermediates" as its development goal. Adhere to the business philosophy of "pursuing excellent product quality and reasonable low cost, and striving to create maximum value for customers to achieve a win-win situation", based on advanced scientific research and production technology, relying on high-quality products, and ensuring high-quality and efficient after-sale technical services To provide a win-win situation for investment managers. At the same time, the company follows the laws of the market, constantly improves the company's management and product production processes, and is committed to creating its own unique production and management system. The company has a standardized production base and high-quality professional production, management and marketing talents. Hairuide Biotechnology will rely on the superior advance awareness of decision-making level, strong financial strength, high-quality professional talents, high-quality and efficient services and all The active and professional dedication of employees, and in the attitude of being socially responsible, continue to march towards excellent national pharmaceutical industry enterprises.
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
United States
DOXYLAMINE SUCCINATE
10 G Sep 25, 2025 
Egypt
Doxylamine Succinate
15.00 KG Mar 18, 2024 Post an enquiry for this product